Research.Patient.info
Gastroenteropancreatic Neuroendocrine Tumors research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE2
Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
This study is looking at a treatment called Lutathera for teenagers aged 12 to 17 with specific types of cancer (GEP-NETs and PPGLs). It aims to see how safe it is and how much medicine goes to the right places in the body.
United States · France · Poland - authorisedTherapeutic use (Phase IV)
Prognostic value of early assessment by ⁶⁸Ga-DOTATATE PET/CT for the treatment of well-differentiated grade 2 gastroenteropancreatic neuroendocrine tumors with ¹⁷⁷Lutetium-oxodotreotide.”
This study looks at how well a special scan (PET/CT) can predict if a treatment called Lutetium-177 will stop certain gut and pancreas cancers from growing. It aims to see if early scan results can tell us if the treatment is working for patients with moderately growing neuroendocrine tumours.
France